MAPT and Parkinson disease: Neurodegenerative diseases are characterized by the aggregation of amyloid-β (Aβ) and hyperphosphorylated tau, and α-synuclein in Alzheimer’s disease (AD) and Parkinson’s disease (PD), respectively.